Repression Of TGF-Β Signaling In Breast Cancer Cells By MiR-302/367 Cluster

Repression Of TGF-Β Signaling In Breast Cancer Cells By MiR-302/367 Cluster

Objective: Tumor necrosis factor-alpha (TNF-α), checkpoint inhibitors, and interleukin-17 (IL-17) are critical targets in inflammation and autoimmune diseases. Monoclonal antibodies (mAbs) have a successful portfolio in the treatment of chronic diseases. With the current progress in stem cells and...

Full description

Bibliographic Details
Main Authors: Mona Ahmadalizadeh Khanehsar, Moslem Hoseinbeyki, Masoumeh Fakhr Taha, Arash Javeri
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2019-08-01
Series:Cell Journal
Subjects:
Gene Therapy
Genetic Vectors
Monoclonal Antibody
Secukinumab
Stem Cells
Online Access:https://celljournal.org/journal/article/fulltext/repression-of-tgf-beta-signaling-in-breast-cancer-cells-by-mir-302-367-cluster.pdf

Internet

https://celljournal.org/journal/article/fulltext/repression-of-tgf-beta-signaling-in-breast-cancer-cells-by-mir-302-367-cluster.pdf

Similar Items